Stockreport

Beta Bionics Announces First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance

Beta Bionics, Inc.  (BBNX) 
PDF IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, [Read more]